Royal Bank of Canada Has $9.73 Million Stock Holdings in Transcat, Inc. $TRNS

Key Points

• Royal Bank of Canada cut its Transcat stake by 17.6% in the first quarter, selling 28,303 shares and retaining 132,447 shares valued at $9.73 million. Institutional investors collectively own 98.34% of the company.
• Transcat exceeded quarterly expectations, reporting $0.51 in EPS versus the $0.38 consensus and $92.95 million in revenue versus $86.55 million expected.
• Despite the earnings beat, analyst sentiment remains cautious: Northland downgraded the stock to “Market Perform” and reduced multiple future EPS forecasts. Transcat trades at an elevated P/E of about 252, while the broader analyst consensus is “Hold.”

Royal Bank of Canada reduced its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 17.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,447 shares of the scientific and technical instruments company's stock after selling 28,303 shares during the quarter. Royal Bank of Canada owned 1.42% of Transcat worth $9,728,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Quantinno Capital Management LP raised its holdings in shares of Transcat by 184.5% in the 1st quarter. Quantinno Capital Management LP now owns 14,548 shares of the scientific and technical instruments company's stock worth $1,069,000 after acquiring an additional 9,434 shares during the last quarter. Rice Hall James & Associates LLC boosted its stake in Transcat by 9.5% during the 1st quarter. Rice Hall James & Associates LLC now owns 38,870 shares of the scientific and technical instruments company's stock valued at $2,855,000 after purchasing an additional 3,368 shares during the last quarter. Punch & Associates Investment Management Inc. increased its holdings in Transcat by 9.4% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 64,775 shares of the scientific and technical instruments company's stock worth $4,758,000 after purchasing an additional 5,540 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company's stock worth $19,244,000 after purchasing an additional 9,266 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky raised its stake in shares of Transcat by 9.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 38,108 shares of the scientific and technical instruments company's stock worth $2,799,000 after purchasing an additional 3,319 shares during the last quarter. 98.34% of the stock is owned by institutional investors.

Key Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat’s latest quarterly results exceeded expectations, with earnings of $0.51 per share versus the $0.38 consensus estimate and revenue of $92.95 million compared with expectations of $86.55 million. This indicates solid operating momentum, although the results are not the primary focus of today’s trading. TRNS Q2 deep dive: Service segment drives growth, margin pressures persist
• Neutral Sentiment: Northland’s $95 price target and “Market Perform” rating indicate a neutral stance rather than a bullish or bearish recommendation. Transcat Rating Lowered to Market Perform at Northland Securities
• Negative Sentiment: Northland cut its Q3 2027 EPS forecast to $0.20 from $0.38 and lowered FY2027 EPS to $1.71 from $1.86. It also reduced estimates for FY2028 to $2.12 from $2.33, FY2029 to $2.58 from $3.18, and FY2030 to $3.01 from $3.51.
• Negative Sentiment: The firm additionally lowered Q2 2027 EPS to $0.41 from $0.45, Q4 2027 EPS to $0.60 from $0.62, and FY2031 EPS to $3.53 from $3.88. The broad-based reductions imply weaker-than-previously-expected earnings growth and are likely weighing on the stock.
• Negative Sentiment: Transcat trades at a very elevated valuation, with a trailing P/E above 250. Downward revisions therefore create greater downside sensitivity, particularly while the stock is near its 52-week high.

Transcat Stock Performance

Shares of TRNS stock opened at $93.11 on Monday. The company has a quick ratio of 2.11, a current ratio of 2.49 and a debt-to-equity ratio of 0.36. The firm has a market cap of $871.51 million, a P/E ratio of 251.65 and a beta of 0.68. The company has a 50 day moving average of $89.60 and a 200-day moving average of $79.73. Transcat, Inc. has a 12-month low of $50.23 and a 12-month high of $96.60.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The scientific and technical instruments company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Transcat had a net margin of 0.99% and a return on equity of 5.56%. The firm had revenue of $92.95 million for the quarter, compared to analysts' expectations of $86.55 million. Sell-side analysts anticipate that Transcat, Inc. will post 1.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Zacks Research upgraded Transcat from a "strong sell" rating to a "hold" rating in a report on Friday, May 15th. Wall Street Zen raised Transcat from a "sell" rating to a "hold" rating in a research report on Sunday, June 28th. Weiss Ratings upgraded Transcat from a "sell (d)" rating to a "sell (d+)" rating in a research note on Thursday, May 28th. Finally, Northland Securities downgraded shares of Transcat from an "outperform" rating to a "market perform" rating and set a $95.00 price objective on the stock. in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $105.50.

Transcat Company Profile

Transcat, Inc NASDAQ: TRNS is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source